EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney Disease

Senthil K Vasan, Rajkumar Chinnadurai, Sharmilee Rengarajan, Darren Green, Helen Alderson, Nicolas Vuilleumier, Philip A Kalra

American Journal of Nephrology · 2025

DOI: 10.1159/000546489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Senthil K Vasan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK. Hauptthemen laut MEDLINE: Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiac biomarkers, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high-sensitivity cardiac troponin-T (Hs-cTnT) are good prognostic indicators of long-term clinical cardiovascular outcomes in patients with chronic kidney disease (CKD). However, the clinical utility of combined biomarkers in predicting death and cardio-renal outcomes in patients with CKD remains unclear. This study examined the prognostic accuracy and incremental value of NT-proBNP and Hs-cTnT for all-cause mortality, major adverse cardiovascular event (MACE), and end-stage kidney disease (ESKD) in non-dialysis-dependent chronic kidney disease (NDD-CKD) patients.

Methods

Data from 1,946 individuals with NDD-CKD prospectively included in the Salford Kidney Study were used to investigate the associations between NT-proBNP and Hs-cTnT with study endpoints. Hazard ratio or sub-hazard ratio and 95% confidence intervals (95% CIs) were estimated using multivariate Cox-regression and competing risk models. The discriminatory power of NT-proBNP and Hs-cTnT along with kidney biomarkers (eGFR and uACR) and Framingham risk score (FRS) were calculated using Harrell’s C-index. Endpoint-specific risk scores were generated using regression coefficients obtained in a training dataset and confirmed in a validation one.

Results

During median follow-up of 71.5 months, 931 (47.8%) deaths, 553 (28.4%) MACE, and 554 (28.5%) ESKD events occurred. Baseline NT-proBNP and Hs-cTnT elevations were associated with significant increased risk of mortality, MACE, and ESKD independently of FRS. Combining NT-proBNP, Hs-cTnT, and FRS yielded the highest prognostic accuracy for all-cause mortality and MACE (respective C-statistics: 0.713; 95% CI: 0.695–0.731, and 0.697; 95% CI: 0.673–0.721), while combining NT-proBNP and Hs-cTnT with eGFR and uACR performed best at predicting ESKD (C-statistics: 0.821; 95% CI: 0.786–0.826).

Conclusion

In NDD-CKD patients, NT-proBNP and Hs-cTnT are predictors of all-cause mortality, MACE, and ESKD, independently of eGFR and uACR. Combining NT-proBNP and Hs-cTnT with eGFR and uACR outperformed risk prediction for ESKD compared to kidney biomarkers used alone or in combination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptide FragmentsNatriuretic Peptide, BrainTroponin TRenal Insufficiency, ChronicCardiovascular DiseasesKidney Failure, ChronicHumansBiomarkersFemalePrognosisMaleAgedMiddle AgedProspective StudiesPredictive Value of TestsRisk Assessment

Stichwörter der Autor:innen

All-cause mortalityCardiac biomarkersEnd-stage kidney diseaseHigh-sensitivity cardiac troponin-TMajor adverse cardiovascular eventN-terminal pro-B-type natriuretic peptide

Substanzen

Peptide FragmentsNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)BiomarkersTroponin T

Autor:innen und Institutionen

  • Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Donal O'Donoghue Renal Research Centre & Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford, UK.
  • National Institute of Health Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK.
  • Division of Laboratory Medicine, Diagnostic Department; Geneva University Hospitals and faculty of Medicine, Geneva, Switzerland.
  • Department of Medicine Specialities, Medical Faculty, Geneva University, Geneva, Switzerland.
  • Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, UK, philip.kalra@nca.nhs.uk.

Zitieren

APA

Vasan, S. K., Chinnadurai, R., Rengarajan, S., Green, D., Alderson, H., Vuilleumier, N., & Kalra, P. A. (2025). Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney Disease. American Journal of Nephrology. https://doi.org/10.1159/000546489

Vancouver

Vasan SK, Chinnadurai R, Rengarajan S, Green D, Alderson H, Vuilleumier N, et al. Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney Disease. American Journal of Nephrology. 2025. doi:10.1159/000546489

BibTeX
@article{Vasan2025,
  author = {Vasan, Senthil K and Chinnadurai, Rajkumar and Rengarajan, Sharmilee and Green, Darren and Alderson, Helen and Vuilleumier, Nicolas and Kalra, Philip A},
  title = {Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney Disease},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000546489}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche